These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 17143262)

  • 21. CD166high Uveal Melanoma Cells Represent a Subpopulation With Enhanced Migratory Capacity.
    Djirackor L; Kalirai H; Coupland SE; Petrovski G
    Invest Ophthalmol Vis Sci; 2019 Jun; 60(7):2696-2704. PubMed ID: 31242292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of the neuroectodermal intermediate filament nestin in human melanomas.
    Flørenes VA; Holm R; Myklebost O; Lendahl U; Fodstad O
    Cancer Res; 1994 Jan; 54(2):354-6. PubMed ID: 8275467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of the stem cell markers CD133 and nestin in pancreatic ductal adenocarcinoma and clinical relevance.
    Kim HS; Yoo SY; Kim KT; Park JT; Kim HJ; Kim JC
    Int J Clin Exp Pathol; 2012; 5(8):754-61. PubMed ID: 23071857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of the hair follicle stem cell marker nestin in patients with malignant melanoma.
    Tanabe K; Amoh Y; Kanoh M; Takasu H; Sakai N; Sato Y; Katsuoka K
    Eur J Dermatol; 2010; 20(3):283-8. PubMed ID: 20156773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation between glioblastoma stem-like cells and tumor vascularization.
    He H; Niu CS; Li MW
    Oncol Rep; 2012 Jan; 27(1):45-50. PubMed ID: 21971709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients.
    Zhang M; Song T; Yang L; Chen R; Wu L; Yang Z; Fang J
    J Exp Clin Cancer Res; 2008 Dec; 27(1):85. PubMed ID: 19108713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of cancer stem cell markers and their correlation with pathogenesis in vascular tumors.
    Lan J; Huang B; Liu R; Ju X; Zhou Y; Jiang J; Liang W; Shen Y; Li F; Pang L
    Int J Clin Exp Pathol; 2015; 8(10):12621-33. PubMed ID: 26722452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nestin expression is associated with aggressive cutaneous melanoma of the nodular type.
    Ladstein RG; Bachmann IM; Straume O; Akslen LA
    Mod Pathol; 2014 Mar; 27(3):396-401. PubMed ID: 24030749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of cancer stem cell markers in sarcomas.
    Veselska R; Skoda J; Neradil J
    Klin Onkol; 2012; 25 Suppl 2():2S16-20. PubMed ID: 23581011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation and partial characterization of a new human glioblastoma cell line.
    Brehar FM; Bleotu C; Stefan LM; Buzgariu W; Chivu M; Utoiu E; Matei L; Ciurea AV; Tascu A
    Chirurgia (Bucur); 2009; 104(4):453-61. PubMed ID: 19886054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SOX2 and nestin expression in human melanoma: an immunohistochemical and experimental study.
    Laga AC; Zhan Q; Weishaupt C; Ma J; Frank MH; Murphy GF
    Exp Dermatol; 2011 Apr; 20(4):339-45. PubMed ID: 21410764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Donor-derived stem-cells and epithelial mesenchymal transition in squamous cell carcinoma in transplant recipients.
    Verneuil L; Leboeuf C; Bousquet G; Brugiere C; Elbouchtaoui M; Plassa LF; Peraldi MN; Lebbé C; Ratajczak P; Janin A
    Oncotarget; 2015 Dec; 6(39):41497-507. PubMed ID: 26594799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nestin expression in cutaneous melanomas and melanocytic nevi.
    Brychtova S; Fiuraskova M; Hlobilková A; Brychta T; Hirnak J
    J Cutan Pathol; 2007 May; 34(5):370-5. PubMed ID: 17448190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nestin and SOX9 and SOX10 transcription factors are coexpressed in melanoma.
    Bakos RM; Maier T; Besch R; Mestel DS; Ruzicka T; Sturm RA; Berking C
    Exp Dermatol; 2010 Aug; 19(8):e89-94. PubMed ID: 19845757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of cell cycle inhibitor p27Kip1 and its inactivator Jab1 in melanocytic lesions.
    Ivan D; Diwan AH; Esteva FJ; Prieto VG
    Mod Pathol; 2004 Jul; 17(7):811-8. PubMed ID: 15154004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased expression of melanoma stem cell marker CD271 in metastatic melanoma to the brain.
    Guo R; Fierro-Fine A; Goddard L; Russell M; Chen J; Liu CZ; Fung KM; Hassell LA
    Int J Clin Exp Pathol; 2014; 7(12):8947-51. PubMed ID: 25674270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aberrant intermediate filament and synaptophysin expression is a frequent event in malignant melanoma: an immunohistochemical study of 73 cases.
    Romano RC; Carter JM; Folpe AL
    Mod Pathol; 2015 Aug; 28(8):1033-42. PubMed ID: 26022451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What is the clinical value of cancer stem cell markers in gliomas?
    Dahlrot RH; Hermansen SK; Hansen S; Kristensen BW
    Int J Clin Exp Pathol; 2013; 6(3):334-48. PubMed ID: 23412423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The intermediate filament peripherin is expressed in cutaneous melanocytic lesions.
    Prieto VG; McNutt NS; Lugo J; Reed JA
    J Cutan Pathol; 1997 Mar; 24(3):145-50. PubMed ID: 9085149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of putative stem marker nestin and CD133 in advanced serous ovarian cancer.
    Qin Q; Sun Y; Fei M; Zhang J; Jia Y; Gu M; Xia R; Chen S; Deng A
    Neoplasma; 2012; 59(3):310-5. PubMed ID: 22296500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.